drugset / Trial / NCT02979704
A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will be conducted to assess the status of oxidative stress inflammation and thrombogenesis in patients with hyperlipidemia and to compare the antioxidative, anti-inflammatory and antithrombogenic effects of rosuvastatin and atorvastatin.
Timeline
- Start
- 2016-09
- Primary completion
- 2017-06
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 10 mg | Oral |
| Comparator | Atorvastatin | Small molecule | 20 mg | Oral |
| Comparator | Rosuvastatin | Small molecule | 5 mg | Oral |
| Comparator | Rosuvastatin | Small molecule | 10 mg | Oral |